Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study

INTRODUCTION: Rasagiline is a selective, irreversible monoamine oxidase B inhibitor that ameliorates the symptoms of Parkinson’s disease (PD) by inhibiting striatal dopamine metabolism. There is also evidence that monoamine oxidase B inhibitors increase melatonin levels in the pineal gland and may h...

Descripción completa

Detalles Bibliográficos
Autores principales: Schettino, Carla, Dato, Clemente, Capaldo, Guglielmo, Sampaolo, Simone, Di Iorio, Giuseppe, Melone, Mariarosa AB
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047735/
https://www.ncbi.nlm.nih.gov/pubmed/27729794
http://dx.doi.org/10.2147/NDT.S116476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047735/
https://www.ncbi.nlm.nih.gov/pubmed/27729794
http://dx.doi.org/10.2147/NDT.S116476

Ejemplares similares